—
C+
C+ The full Closelooknet — membership. Open the C+ overview

AbbVie Inc (ABBV) — Technical state

As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Uptrend stack intact — Trades +9% vs the 50-day and +24.1% vs the 200-day average, 1.3% below the 52-week high and +54.6% off the 52-week low. Computed from daily closes. (as of 2026-11-04)
  • Trend: AbbVie Inc trades 9.0% above its 50-day and 24.1% above its 200-day moving average. (as of 2026-11-04)

AbbVie is a biopharmaceutical company that researches, makes and sells medicines and treatments worldwide. Its range covers Skyrizi and Rinvoq for immune disease, Imbruvica and Venclexta for blood cancers, Elahere and Epkinly for other cancers, and Botox and Juvederm for aesthetic use.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ABBV overview. Research diary readings, not advice.

Uptrend stack intact

Trades +9% vs the 50-day and +24.1% vs the 200-day average, 1.3% below the 52-week high and +54.6% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the ABBV chart & overview · the signal board

FAQ · from the current data · as of 2026-11-04

Quick answers

What is the current Closelooknet signal on ABBV?

Uptrend stack intact — Trades +9% vs the 50-day and +24.1% vs the 200-day average, 1.3% below the 52-week high and +54.6% off the 52-week low. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ABBV above its 50-day and 200-day moving averages?

As of 2026-11-04, AbbVie Inc trades +9% above its 50-day and +24.1% above its 200-day average, with the 20-day +3.6% away.

How far is ABBV from its 52-week high?

1.3% below the 52-week high and 54.6% above the 52-week low, as of 2026-11-04.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.